Savara Announces Participation in the Upcoming Citizens Life Sciences Conference
The live webcast and subsequent replay will be available on the 'Events & Presentations' section of the Company's corporate website at https://savarapharma.com/investors/events-presentations/ and will be archived for 90 days.
About Savara
Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases. Our lead program, MOLBREEVI*, is a recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). MOLBREEVI is delivered via an investigational eFlow ® Nebulizer System (PARI Pharma GmbH) specifically developed for inhalation of a large molecule. Our management team has significant experience in rare respiratory diseases and pulmonary medicine, identifying unmet needs, and effectively advancing product candidates to approval and commercialization. More information can be found at www.savarapharma.com, and LinkedIn.
*MOLBREEVI is the FDA and EMA conditionally accepted trade name for molgramostim inhalation solution. It is not approved in any indication. MOLBREEVI is a trademark of Savara Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Why Rigetti Computing Stock Is Sinking Today
Key Points Q2 revenue was $1.8 million, down roughly 42% year over year; net loss neared $40 million. Soft jobs data and hotter-than-expected inflation data weighed on risk assets like quantum stocks. 10 stocks we like better than Rigetti Computing › Shares of Rigetti Computing (NASDAQ: RGTI) are sinking on Tuesday, down 8.7% as of 2:46 p.m. ET. The drop comes as the S&P 500 loses 0.7% and the Nasdaq Composite loses 1.5%. The quantum computing company's stock is continuing its slide after its recent earnings failed to impress investors and as macro concerns about the direction of the economy are leading investors to jump out of risky stocks. Rigetti Computing stock drops on weak Q2 and macro jitters Last week, Rigetti released its Q2 report, revealing that its sales and earnings were down significantly year over year. The company's $1.8 million in revenue was nearly 42% less than last year in the same period, and its net income dropped nearly 220% as the company lost nearly $40 million in the quarter. While the loss was exacerbated by some one-off accounting charges, the performance still showed how far the company is from justifying its current market cap of nearly $5 billion. Adding to the pain, recent economic data is putting pressure on riskier stocks like Rigetti. The latest jobs report shows the economy may be slowing, while at the same time, inflation numbers came in higher than expected. Investors should be cautious The company did share some promising operational updates and leaps in its technological development in its earnings release, but I believe we are likely many, many years, if not decades, away from viable quantum computing. Despite this, Rigetti and other quantum computing companies are reaching multibillion-dollar valuations already. I think there is a major disconnect here, and quantum investors may get burned if the economy does really take a dive. Should you buy stock in Rigetti Computing right now? Before you buy stock in Rigetti Computing, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Rigetti Computing wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $671,466!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,115,633!* Now, it's worth noting Stock Advisor's total average return is 1,076% — a market-crushing outperformance compared to 184% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 18, 2025 Johnny Rice has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why Rigetti Computing Stock Is Sinking Today was originally published by The Motley Fool Sign in to access your portfolio
Business Wire
22 minutes ago
- Business Wire
Susan G. Komen ® To Host 2025 Northeast Ohio MORE THAN PINK Walk This September
CLEVELAND--(BUSINESS WIRE)-- Susan G. Komen ®, the world's leading breast cancer organization, will convene breast cancer survivors, those living with metastatic breast cancer (MBC) and supporters at the 2025 Susan G. Komen Northeast Ohio MORE THAN PINK Walk. This impactful event unites our community and raises money for the mission of Komen, supporting those affected by breast cancer. Komen aims to raise over $350,000 at the Northeast Ohio MORE THAN PINK Walk, generating critical funds that allow Komen to continue its investment in lifesaving work across the country, including promising research that will allow people to live longer lives with better outcomes. This event also funds Komen's Patient Care Center, a trusted, go-to source for timely, accurate breast health and breast cancer information, support and resources, as well as the work of Komen's Center for Public Policy to drive state and federal policies that invest in critical programs and ensure streamlined access to affordable, high-quality breast health care. WHEN: Saturday, September 20, 2025 WHERE: Wade Oval - 10820 East Blvd, Cleveland, OH 44106 WHY IT MATTERS: Breast cancer affects 1 in 8 women in the U.S. and 1 in 1,000 men in their lifetime. In 2025 alone, an estimated 316,950 women in the U.S. will be diagnosed with breast cancer and 42,170 women will die from the disease. Approximately 2,800 men will be diagnosed with breast cancer and 510 will die from it. However, some experts say one-third of breast cancer deaths in the U.S. could be prevented with universal access to modern treatments. In Ohio, approximately over 77,000 people will be diagnosed with breast cancer and over 24,000 will die from the disease this year. Susan G. Komen provides direct support to Ohioans through its Patient Care Center. In fiscal year 2025, Komen provided assistance to over 1,300 patients, including over $358,000 in financial assistance to eligible people in active treatment or living with metastatic breast cancer. 'The work Komen does for people with breast cancer, survivors and those with increased risk of breast cancer is not possible without the Northeast Ohio MORE THAN PINK Walk and the critical money we raise from our generous supporters,' said Sean Shacklett, executive director Ohio & Michigan at Susan G. Komen. 'We look forward to bringing together the Northeast Ohio community this fall and uniting around our goal of creating a world where we do not lose another life to this disease.' Bank of America is the national presenting sponsor and Lilly, Natera, and Novartis are national series sponsors for the MORE THAN PINK Walk and Race for the Cure events. About Susan G. Komen ® Susan G. Komen ® is the world's leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy's life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow's cures. Visit or call 1-877 GO KOMEN. Connect with us on social at
Yahoo
an hour ago
- Yahoo
Top analysts pick 3 favorite crypto mining stocks
Top analysts pick 3 favorite crypto mining stocks originally appeared on TheStreet. One of the foundational industries in the blockchain and crypto space, crypto mining has firmly established itself as a prominent player in the global technology sector. Pioneering companies from the crypto mining industry have gone on to become one of the most dependable bets in the markets. To put it simply, crypto mining is the process of using high-end computers to solve complex cryptographic puzzles to validate and add transactions to a blockchain network. It requires a lot of computing power to solve these functions, and the reward in the form of newly minted crypto assets is quite lucrative. That is why we have witnessed an extraordinary emergence of crypto mining firms in several parts of the world, but the U.S. takes the lead in mining operations. Despite the doubts surrounding the crypto industry in general, these mining companies have cemented themselves as emergent leaders in the global technology market over the years. Of late, such firms have also invited the attention of several well-established giants and even succeeded in persuading them to open their coffers to support crypto mining operations. Institutions open coffers for crypto mining Whether it's the Trump family or Jack Dorsey or Google, nobody has been able to escape the charm of the lucrative industry. But the traditional tech industry embracing the disruptive crypto industry wouldn't seem like an unusual phenomenon if we carefully look at the numbers. After all, Bitcoin — the premier cryptocurrency that the crypto mining industry primarily focuses on — has been hitting new all-time highs over the past few months. Bitcoin mining profits reached their highest monthly mark in July since the last halving in April 2024, JP Morgan analysts wrote in a recent note. Miners earned as much as an average of $57,400 per EH/s in daily block reward revenue the last month. In this story, we look at three crypto mining stocks that the leading analysts are talking about. TeraWulf Inc. TeraWulf Inc. (Nasdaq: WULF) is a Bitcoin mining and high-performance computing (HPC) firm that recently came under the spotlight following Google, Alphabet's (Nasdaq: GOOGL) iconic tech brand, acquiring a 14% stake in it. Google is now the largest shareholder of TeraWulf. 'Fluidstack's decision to expand so soon after our initial agreement speaks volumes about the quality, readiness, and scalability of our infrastructure,' TeraWulf CTO Nazar Khan said of the latest expansion drive with AI cloud provider Fluidstack. On Aug. 8, TeraWulf revealed that its Bitcoin mining capacity grew 45.5% YoY to 12.8 EH/s during Q2 2025. It mined 485 BTC during Q2 2025, as compared to 699 BTC during Q2 2024. Cantor Fitzgerald analyst Brett Knoblauch has raised the price target on WULF from $11 to $14 and maintained an "Overweight" rating. The stock was trading at $9.02 at press time, down 3.5% a day. HIVE Digital HIVE Digital Technologies (Nasdaq: HIVE) is one of the earliest and most well-established Bitcoin mining firms in the world, which has a global footprint in Canada, Sweden, and Paraguay. On July 8, the firm revealed that its monthly Bitcoin production rose 18% in June. It is counting on its burgeoning Phase 2 unit in Paraguay and AI technology. Roth Capital Markets analyst Darren Aftahi has kept the price target on HIVE at $6 and maintained a "Buy" rating. The stock was trading at $2.3801 at the time of writing, up 0.4262% a day. Riot Platforms Riot Platforms (Nasdaq: RIOT) is a leading Bitcoin mining firm that is headquartered in Colorado. It also focuses on developing a portion of its power capacity for AI and HPC uses. On July 31, the firm revealed that its Bitcoin production grew more than 65% YoY during Q2 2025. Riot mined 1,426 BTC during the last quarter. Cantor Fitzgerald's Brett Knoblauch has kept the price target on RIOT at $24 and maintained a "Buy rating." The stock was trading at $12.15, down 1.34% a day. Top analysts pick 3 favorite crypto mining stocks first appeared on TheStreet on Aug 19, 2025 This story was originally reported by TheStreet on Aug 19, 2025, where it first appeared. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
